Lifetime Membership
The IASRM Commercialization Committee consists of a mix of cell therapy companies and academic thought leaders with the mandate of identifying and challenging the roadblocks to commercialization. The Commercialization Committee meets for 1 hour, once a month and sets the strategic direction for the Industry Community.
Access Key Opinion Leaders in cell and gene therapy translation via IASRM Pillars of Value:
- Academia
- Regulatory
- Commercialization
Participate in the IASRM Commercialization Committee or Sub-Committees to drive clinical translation
The IASRM Commercialization Committee consists of a mix of stem cell companies and academic thought leaders with the mandate of identifying and challenging the roadblocks to commercialization. The Commercialization Committee meets for 1 hour, once a month and sets the strategic direction for the Industry Community.
There are three Sub-Committees which report into the Commercialization Committee:
- Process and Product Development
- Business Models & Investment
- Market Access and Patient Advocacy
All account and sub-account holders receive access to:
- Commercialization Committee monthly meeting minutes
- All Sub-Committee meeting minutes
Participation within the Commercialization Committee and/or Sub-Committees is contingent on an Industry Community Membership with IASRM as outlined below.
Members-Only access to IASRM resources:
- Past meeting and webinar presentations
- Online networking directory and member profiles
- External partner meeting reports (eg. FDA Stem Cell Therapy)
Marketing Benefits Include:
Base Benefits:
- 1 FREE job posting on the IASRM Website
- Target IASRM membership with 1 free advertisement